RAB33B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.176200E-01
Normal-vs-Stage2
1.638850E-01
Normal-vs-Stage3
7.970400E-04
Normal-vs-Stage4
7.686400E-01
Stage1-vs-Stage2
1.702640E-01
Stage1-vs-Stage3
3.772300E-02
Stage1-vs-Stage4
5.323600E-01
Stage2-vs-Stage3
2.318500E-03
Stage2-vs-Stage4
4.009800E-02
Stage3-vs-Stage4
8.353800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.961780E-01
Normal-vs-AfricanAmerican
6.737600E-01
Normal-vs-Asian
1.635760E-01
Caucasian-vs-AfricanAmerican
2.908000E-01
Caucasian-vs-Asian
5.964800E-01
AfricanAmerican-vs-Asian
2.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.844820E-01
Normal-vs-Female
2.709600E-01
Male-vs-Female
4.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.655430E-01
Normal-vs-Age(41-60Yrs)
5.323400E-01
Normal-vs-Age(61-80Yrs)
1.398570E-01
Normal-vs-Age(81-100Yrs)
9.198300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.664400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.881400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.272400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.237700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.541900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.209770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.818400E-02
Normal-vs-Daily Drinker
5.455700E-02
Normal-vs-Weekly Drinker
8.612100E-02
Normal-vs-Occasional Drinker
5.186800E-01
Normal-vs-Social Drinker
5.487800E-01
Non Drinker-vs-Daily Drinker
3.795400E-01
Non Drinker-vs-Weekly Drinker
7.010000E-01
Non Drinker-vs-Occasional Drinker
9.293500E-02
Non Drinker-vs-Social Drinker
1.854020E-01
Daily Drinker-vs-Weekly Drinker
7.263400E-01
Daily Drinker-vs-Occasional Drinker
3.326000E-02
Daily Drinker-vs-Social Drinker
8.194000E-02
Weekly Drinker-vs-Occasional Drinker
1.115360E-01
Weekly Drinker-vs-Social Drinker
2.061800E-01
Occasional Drinker-vs-Social Drinker
9.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.056400E-02
Normal-vs-Grade 2
3.544000E-03
Normal-vs-Grade 3
2.677600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.112800E-01
Grade 1-vs-Grade 3
8.264200E-01
Grade 1-vs-Grade 4
7.056400E-02
Grade 2-vs-Grade 3
8.598800E-01
Grade 2-vs-Grade 4
3.544000E-03
Grade 3-vs-Grade 4
2.677600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.784400E-02
Normal-vs-NonDiabetic
1.913980E-01
Diabetic-vs-NonDiabetic
2.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.043700E-02
Normal-vs-NoPancreatitis
1.945360E-01
Pancreatitis-vs-NoPancreatitis
2.710800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.128800E-01
Normal-vs-N1
1.829040E-01
N0-vs-N1
9.591800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.843400E-01
Normal-vs-TP53-NonMutant
5.798600E-01
TP53-Mutant-vs-TP53-NonMutant
4.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
